Anti-Cancer Drugs Journal Issues Research Articles in August 2023 Edition
August 12, 2023
August 12, 2023
LONDON, England, Aug. 12 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its August 2023 edition:
Pre-Clinical Reports:
* A novel ribociclib derivative WXJ-103 exerts anti-breast cancer effect through C . . .
Pre-Clinical Reports:
* A novel ribociclib derivative WXJ-103 exerts anti-breast cancer effect through C . . .